Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
Urdl, W.
Hormonal replacement therapy in patients with cervical and ovarian cancers
Gynakol Geburtshilfliche Rundsch. 1998; 38(2): 89-92.
Doi: 10.1159/000022240
Web of Science
PubMed
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
- Urdl Wolfgang
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Hormonal replacement therapy in women following primary treatment for squamous cell carcinoma of the cervix uteri is harmless. In case of adenocarcinoma of the cervix, guidelines for hormonal replacement therapy according to those valid for endometrial cancer are recommended. In women treated for ovarian cancer, a combined cyclic or continuous estrogen/gestagen substitution - the latter also in hysterectomized women - is to be favored. Signs of androgen deficiency are to be respected. Short-term clinical, sonographical, and biochemical control investigations are recommended.
- Find related publications in this database (using NLM MeSH Indexing)
- Adenocarcinoma - chemically induced
- Carcinoma, Squamous Cell - chemically induced
- Combined Modality Therapy - chemically induced
- English Abstract - chemically induced
- Estrogen Replacement Therapy - contraindications
- Female - contraindications
- Humans - contraindications
- Hysterectomy - contraindications
- Ovarian Neoplasms - chemically induced
- Progestins - administration and dosage
- Risk Factors - administration and dosage
- Uterine Cervical Neoplasms - chemically induced
- Find related publications in this database (Keywords)
- hormonal replacement therapy
- cervical cancer
- ovarian cancer